Facial hypertrichosis and trichomegaly developing in patients treated with the epidermal growth factor receptor inhibitor erlotinib
We report three patients who developed facial hypertrichosis and eyelash trichomegaly while receiving erlotinib.
Continue reading here:
Facial hypertrichosis and trichomegaly developing in patients treated with the epidermal growth factor receptor inhibitor erlotinib
Comments
Leave a Reply